Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
215.6 USD | -0.33% | -2.32% | -16.67% |
Mar. 25 | Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell | MT |
Mar. 19 | BIOGEN : Jefferies confirms its Buy rating on the stock | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 31.34B | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B | |
-11.81% | 7.82B |
- Stock
- Equities
- Stock Biogen Inc. - Nasdaq
- News Biogen Inc.
- Biogen Q1 Non-GAAP EPS, Revenue Drop; CEO Michel Vounatsos to Leave; Reaffirms 2022 Guidance